Grufity logoGrufity logo
StocksFundsSearch Filings

Cigna Corp Stock Research

CI

244.10USD-2.97(-1.20%)Market Closed

Market Summary

USD244.10-2.97
Market Closed
-1.20%

CI Alerts

CI Stock Price

CI RSI Chart

CI Valuation

Market Cap

91.1B

Price/Earnings (Trailing)

13.64

Price/Sales (Trailing)

1.92

EV/EBITDA

8.96

Price/Free Cashflow

8.41

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

4.63%

Return on Equity

15.03%

Return on Assets

4.69%

Free Cashflow Yield

11.89%

CI Fundamentals

CI Revenue

Revenue (TTM)

183.0B

Revenue Y/Y

5.71%

Revenue Q/Q

1.67%

CI Earnings

Earnings (TTM)

6.7B

Earnings Y/Y

5.74%

Earnings Q/Q

-56.88%

Price Action

52 Week Range

237.34338.66
(Low)(High)

CI Financial Health

Current Ratio

0.73

Debt/Equity

0.63

Debt/Cashflow

0.31

CI Investor Care

Dividend Yield

1.88%

Dividend/Share (TTM)

4.59

Diluted EPS (TTM)

21.99

Peers (Alternatives to Cigna)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
448.8B
335.9B
- -
21.68
1.34
12.90% 18.65%
91.1B
183.0B
- -
13.64
1.92
3.34% 24.58%
65.7B
95.6B
- -
23.41
0.71
10.74% 2.64%
34.6B
146.3B
- -
23.33
0.24
9.81% -0.94%
MID-CAP
5.2B
2.3B
- -
86.23
2.28
2.85% -58.05%
4.7B
861.7M
- -
-178.64
5.42
13.90% 40.97%
3.9B
4.8B
- -
10.12
0.8
3.57% -4.88%
3.4B
704.5M
- -
49.59
4.78
13.56% 10.15%
2.6B
6.4B
- -
13.26
0.41
-0.52% 16.73%
SMALL-CAP
1.7B
1.5B
- -
-126.07
1.14
10.24% -173.11%
1.4B
976.1M
- -
28.65
1.47
10.19% 12.37%
645.6M
2.9B
- -
-3.53
0.22
7.97% -101.02%

Financials for Cigna

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue1.4%183,028180,516180,453179,461177,112
  S&GA Expenses1.8%13,42513,18613,36513,31013,050
EBITDA0.1%12,51912,5088,18911,032-
EBITDA Margin0.1%0.07*0.07*0.18*0.06*-
Earnings Before Taxes0.6%8,4058,3538,3376,9056,818
EBT Margin0.2%0.05*0.05*0.15*0.04*-
Interest Expenses1.1%1,2431,2291,2261,2291,230
Net Income1.0%6,7466,6815,5385,442-
Net Income Margin0.9%0.04*0.04*0.12*0.03*-
Free Cahsflow-20.1%8,65610,8329,6688,128-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets2.8%147,976143,932144,209152,630152,610
  Current Assets6.3%32,02730,12030,17037,42235,393
    Cash Equivalents34.9%7,9895,9247,0794,4214,424
  Inventory-11.8%4,2114,7774,0173,7813,500
  Goodwill0%45,81145,81145,80745,81045,804
Liabilities4.4%103,38098,98199,076106,663106,446
  Current Liabilities8.5%44,72741,22941,11545,21843,662
  Long Term Debt3.6%29,12428,10028,09030,98431,013
Shareholder's Equity-0.8%44,51844,87245,04145,92246,109
  Retained Earnings2.6%38,84137,87437,04134,62633,420
  Additional Paid-In Capital0.3%30,33230,23329,39529,93029,736
Minority Interest23.1%16.0013.0042.0030.0022.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations34.6%11,6548,65610,8329,6688,128
Cashflow From Investing-85.8%4393,0983,837-1,319-3,218
Cashflow From Financing19.0%-9,106-11,240-10,975-7,186-6,332
  Buy Backs-5.3%7,2017,6077,2956,4066,316

Risks for CI

What is the probability of a big loss on CI?

null%


Probability that Cigna stock will be more than 20% underwater in next one year

null%


Probability that Cigna stock will be more than 30% underwater in next one year.

null%


Probability that Cigna stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cigna was unfortunately bought at previous high price.

Drawdowns

Returns for CI

Cumulative Returns on CI

What are the long-term rolling returns for CI?

FIve years rolling returns for Cigna.

Annualized Returns

Which funds bought or sold CI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-05-26
ProShare Advisors LLC
added
11.58
-2,215,320
13,667,800
0.04%
2023-05-25
Brandywine Global Investment Management, LLC
added
183
99,677,800
183,856,000
0.74%
2023-05-25
Empower Advisory Group, LLC
new
-
1,064,240
1,064,240
-%
2023-05-24
Old North State Trust, LLC
unchanged
-
-2,000
6,000
-%
2023-05-23
Toroso Investments, LLC
added
70.44
1,390,000
5,814,000
0.10%
2023-05-23
3Chopt Investment Partners, LLC
new
-
2,536,200
2,536,200
1.35%
2023-05-23
Brookfield Corp /ON/
added
2.84
-3,875,990
14,858,300
0.06%
2023-05-23
Front Row Advisors LLC
reduced
-16.84
-11,000
20,000
0.01%
2023-05-22
AMERIPRISE FINANCIAL INC
added
22.73
-62,839,300
1,110,600,000
0.36%
2023-05-22
American Trust
reduced
-72.95
-913,348
240,709
0.02%

1–10 of 45

Latest Funds Activity

Are funds buying CI calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CI
No. of Funds

Cigna News

MarketBeat
The Cigna Group (NYSE:CI) Releases FY 2023 Earnings Guidance.
MarketBeat,
22 hours ago
Nasdaq
Yahoo Finance
StockNews.com
Zacks Investment Research
The Motley Fool

Schedule 13G FIlings of Cigna

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
dodge & cox
3.8%
11,548,557
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.5%
13,656,608
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
vanguard group inc
8.37%
25,583,766
SC 13G/A
Feb 07, 2023
blackrock inc.
9.0%
27,469,496
SC 13G
Feb 14, 2022
dodge & cox
5.3%
17,484,197
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.4%
17,961,332
SC 13G/A
Feb 09, 2022
vanguard group inc
7.88%
26,120,848
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 03, 2022
blackrock inc.
8.9%
29,587,276
SC 13G/A

CI Fair Value

Recent SEC filings of Cigna

View All Filings
Date Filed Form Type Document
May 24, 2023
4
Insider Trading
May 10, 2023
4
Insider Trading
May 05, 2023
10-Q
Quarterly Report
May 05, 2023
8-K
Current Report
May 03, 2023
4
Insider Trading
May 01, 2023
144
Notice of Insider Sale Intent
May 01, 2023
8-K
Current Report
Apr 28, 2023
8-K
Current Report
Apr 28, 2023
4
Insider Trading
Apr 28, 2023
4
Insider Trading

Latest Insider Trading transactions for CI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-22
Agoglia Hoeltzel Mary T
sold
-128,374
254
-503
svp tax & chief acct. officer
2023-05-08
Palmer Eric P
gifted
-
-
390
president & ceo, evernorth
2023-05-08
Palmer Eric P
gifted
-
-
-390
president & ceo, evernorth
2023-05-01
ZARCONE DONNA F
sold
-191,741
253
-757
-
2023-04-26
McClellan Mark B.
acquired
-
-
765
-
2023-04-26
MAZZARELLA KATHLEEN M
acquired
-
-
765
-
2023-04-26
DeLaney William J III
acquired
-
-
765
-
2023-04-26
Granger Elder
acquired
-
-
765
-
2023-04-26
Hathi Neesha
acquired
-
-
765
-
2023-04-26
Kurian George
acquired
-
-
765
-

1–10 of 50

David M. Cordani
65535
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CI Income Statement

2023-03-31
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
[1]
Revenues  
Premiums$ 11,025$ 10,356
Net investment income277414
TOTAL REVENUES46,51744,006
Benefits and expenses  
Pharmacy and other service costs31,45929,813
Medical costs and other benefit expenses9,0468,272
Selling, general and administrative expenses3,5383,275
Amortization of acquired intangible assets459458
TOTAL BENEFITS AND EXPENSES44,50241,818
Income from operations2,0152,188
Interest expense and other(358)(299)
Net realized investment losses(56)(322)
Income before income taxes1,6011,567
TOTAL INCOME TAXES295355
Net income1,3061,212
Less: Net income attributable to noncontrolling interests3915
SHAREHOLDERS' NET INCOME$ 1,267$ 1,197
Shareholders' net income per share  
Basic (in dollars per share)$ 4.28$ 3.76
Diluted (in dollars per share)$ 4.24$ 3.73
Pharmacy revenues  
Revenues  
Revenues$ 32,144$ 30,697
Fees and other revenues  
Revenues  
Revenues$ 3,071$ 2,539
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.

CI Balance Sheet

2023-03-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
[1]
Assets  
Cash and cash equivalents$ 7,935$ 5,924
Investments914905
Accounts receivable, net17,70417,218
Inventories4,2114,777
Other current assets1,2631,298
Total current assets32,02730,122
Long-term investments19,01016,288
Reinsurance recoverables5,2865,416
Property and equipment3,8373,774
Goodwill45,81145,811
Other intangible assets32,10232,492
Other assets2,5632,704
Separate account assets7,3407,278
TOTAL ASSETS147,976143,885
Liabilities  
Current insurance and contractholder liabilities7,1665,409
Pharmacy and other service costs payable17,60917,070
Accounts payable7,3607,775
Accrued expenses and other liabilities9,1747,978
Short-term debt3,4182,993
Total current liabilities44,72741,225
Non-current insurance and contractholder liabilities11,79011,976
Deferred tax liabilities, net7,7077,786
Other non-current liabilities2,6922,766
Long-term debt29,12428,100
Separate account liabilities7,3407,278
TOTAL LIABILITIES103,38099,131
Contingencies — Note 16
Redeemable noncontrolling interests7866
Shareholders' equity  
Common stock[2]44
Additional paid-in capital30,33230,233
Accumulated other comprehensive loss(1,769)(1,658)
Retained earnings38,84137,940
Less: Treasury stock, at cost(22,906)(21,844)
TOTAL SHAREHOLDERS' EQUITY44,50244,675
Other noncontrolling interests1613
Total equity44,51844,688[3]
Total liabilities and equity$ 147,976$ 143,885
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.
[2]Par value per share, $0.01; shares issued, 399 million as of March 31, 2023 and 398 million as of December 31, 2022; authorized shares, 600 million.
[3]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.